Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Sfxn3 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of SFXN3 mRNA | CTD | PMID:22206623 | Sfxn3 | Rat | 17alpha-ethynylestradiol | affects expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Ethinyl Estradiol affects the expression of SFXN3 mRNA | CTD | PMID:17555576 | Sfxn3 | Rat | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | 2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of SFXN3 mRNA | CTD | PMID:19095052 | Sfxn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of SFXN3 mRNA | CTD | PMID:22298810 | Sfxn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SFXN3 mRNA | CTD | PMID:33387578 | Sfxn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SFXN3 mRNA | CTD | PMID:28213091 | Sfxn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SFXN3 mRNA | CTD | PMID:20959002 | Sfxn3 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SFXN3 mRNA | CTD | PMID:20106945|PMID:21632981 | Sfxn3 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of SFXN3 mRNA | CTD | PMID:20188158 | Sfxn3 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of SFXN3 mRNA | CTD | PMID:28973697 | Sfxn3 | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of SFXN3 mRNA | CTD | PMID:36843608 | Sfxn3 | Rat | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of SFXN3 mRNA | CTD | PMID:31881176 | Sfxn3 | Rat | acrolein | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SFXN3 more ... | CTD | PMID:32699268 | Sfxn3 | Rat | Aflatoxin B2 alpha | increases methylation | ISO | SFXN3 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of SFXN3 intron | CTD | PMID:30157460 | Sfxn3 | Rat | all-trans-retinoic acid | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SFXN3 mRNA | CTD | PMID:33167477 | Sfxn3 | Rat | alpha-pinene | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SFXN3 more ... | CTD | PMID:32699268 | Sfxn3 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of SFXN3 mRNA | CTD | PMID:16483693 | Sfxn3 | Rat | arsane | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Sfxn3 | Rat | arsenic atom | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Sfxn3 | Rat | benzo[a]pyrene | affects methylation | ISO | SFXN3 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SFXN3 3' UTR; Benzo(a)pyrene affects the methylation of SFXN3 exon; more ... | CTD | PMID:27901495|PMID:30157460 | Sfxn3 | Rat | beta-naphthoflavone | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SFXN3 mRNA | CTD | PMID:18164116 | Sfxn3 | Rat | beta-naphthoflavone | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | beta-Naphthoflavone results in decreased expression of SFXN3 protein | CTD | PMID:39638853 | Sfxn3 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SFXN3 protein | CTD | PMID:31163220 | Sfxn3 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of SFXN3 mRNA | CTD | PMID:33754040 | Sfxn3 | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of SFXN3 mRNA | CTD | PMID:34319233 | Sfxn3 | Rat | bis(2-ethylhexyl) phthalate | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SFXN3 more ... | CTD | PMID:33872906 | Sfxn3 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Diethylhexyl Phthalate results in increased expression of SFXN3 mRNA | CTD | PMID:31163220 | Sfxn3 | Rat | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SFXN3 mRNA | CTD | PMID:25181051 | Sfxn3 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SFXN3 mRNA | CTD | PMID:30816183|PMID:32528016 | Sfxn3 | Rat | bisphenol A | affects expression | ISO | SFXN3 (Homo sapiens) | 6480464 | bisphenol A affects the expression of SFXN3 mRNA | CTD | PMID:30903817 | Sfxn3 | Rat | bisphenol AF | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | bisphenol AF results in increased expression of SFXN3 protein | CTD | PMID:34186270 | Sfxn3 | Rat | Bisphenol B | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | bisphenol B results in increased expression of SFXN3 protein | CTD | PMID:34186270 | Sfxn3 | Rat | bisphenol F | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of SFXN3 protein | CTD | PMID:34186270 | Sfxn3 | Rat | Butylbenzyl phthalate | increases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased expression of SFXN3 mRNA | CTD | PMID:28392331 | Sfxn3 | Rat | cadmium atom | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Cadmium results in decreased expression of SFXN3 mRNA | CTD | PMID:23369406 | Sfxn3 | Rat | cadmium dichloride | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of SFXN3 mRNA | CTD | PMID:38568856 | Sfxn3 | Rat | caffeine | increases phosphorylation | ISO | SFXN3 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of SFXN3 protein | CTD | PMID:35688186 | Sfxn3 | Rat | calcitriol | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of SFXN3 mRNA | CTD | PMID:16002434 | Sfxn3 | Rat | carbamazepine | affects expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of SFXN3 mRNA | CTD | PMID:25979313 | Sfxn3 | Rat | chlordecone | increases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Chlordecone results in increased expression of SFXN3 mRNA | CTD | PMID:33711761 | Sfxn3 | Rat | choline | multiple interactions | ISO | Sfxn3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Sfxn3 | Rat | cisplatin | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SFXN3 mRNA | CTD | PMID:27594783 | Sfxn3 | Rat | cyclosporin A | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of SFXN3 mRNA | CTD | PMID:20106945|PMID:25562108|PMID:27989131 | Sfxn3 | Rat | cyclosporin A | decreases methylation | ISO | SFXN3 (Homo sapiens) | 6480464 | Cyclosporine results in decreased methylation of SFXN3 promoter | CTD | PMID:27989131 | Sfxn3 | Rat | deoxynivalenol | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of SFXN3 protein | CTD | PMID:39638853 | Sfxn3 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of SFXN3 mRNA | CTD | PMID:21266533 | Sfxn3 | Rat | dorsomorphin | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Sfxn3 | Rat | doxorubicin | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SFXN3 mRNA | CTD | PMID:29803840 | Sfxn3 | Rat | endosulfan | decreases expression | EXP | | 6480464 | Endosulfan results in decreased expression of SFXN3 mRNA | CTD | PMID:29391264 | Sfxn3 | Rat | entinostat | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | entinostat results in increased expression of SFXN3 mRNA | CTD | PMID:27188386 | Sfxn3 | Rat | fipronil | increases expression | EXP | | 6480464 | fipronil results in increased expression of SFXN3 mRNA | CTD | PMID:34044035 | Sfxn3 | Rat | folic acid | multiple interactions | ISO | Sfxn3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Sfxn3 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of SFXN3 mRNA | CTD | PMID:27387713 | Sfxn3 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SFXN3 mRNA | CTD | PMID:22061828 | Sfxn3 | Rat | inulin | multiple interactions | ISO | Sfxn3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SFXN3 mRNA | CTD | PMID:36331819 | Sfxn3 | Rat | ivermectin | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of SFXN3 protein | CTD | PMID:32959892 | Sfxn3 | Rat | L-methionine | multiple interactions | ISO | Sfxn3 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression more ... | CTD | PMID:20938992 | Sfxn3 | Rat | leflunomide | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of SFXN3 mRNA | CTD | PMID:28988120|PMID:29427785 | Sfxn3 | Rat | lipopolysaccharide | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Lipopolysaccharides results in decreased expression of SFXN3 mRNA | CTD | PMID:35811015 | Sfxn3 | Rat | lipopolysaccharide | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SFXN3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Sfxn3 | Rat | manganese atom | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Sfxn3 | Rat | manganese(0) | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Sfxn3 | Rat | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of SFXN3 mRNA | CTD | PMID:28801915 | Sfxn3 | Rat | manganese(II) chloride | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Sfxn3 | Rat | manganese(II) chloride | decreases methylation | EXP | | 6480464 | manganese chloride results in decreased methylation of SFXN3 gene | CTD | PMID:28801915 | Sfxn3 | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of SFXN3 mRNA | CTD | PMID:38685447 | Sfxn3 | Rat | mono(2-ethylhexyl) phthalate | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [Diethylhexyl Phthalate results in increased abundance of mono-(2-ethylhexyl)phthalate] which results in increased methylation of SFXN3 more ... | CTD | PMID:33872906 | Sfxn3 | Rat | Muraglitazar | decreases expression | EXP | | 6480464 | muraglitazar results in decreased expression of SFXN3 mRNA | CTD | PMID:21515302 | Sfxn3 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of SFXN3 mRNA | CTD | PMID:18164116 | Sfxn3 | Rat | okadaic acid | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Okadaic Acid results in decreased expression of SFXN3 mRNA | CTD | PMID:38832940 | Sfxn3 | Rat | ozone | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] affects the expression of SFXN3 more ... | CTD | PMID:32699268 | Sfxn3 | Rat | paracetamol | affects expression | ISO | Sfxn3 (Mus musculus) | 6480464 | Acetaminophen affects the expression of SFXN3 mRNA | CTD | PMID:17562736 | Sfxn3 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SFXN3 mRNA | CTD | PMID:33387578 | Sfxn3 | Rat | paracetamol | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of SFXN3 mRNA | CTD | PMID:25704631|PMID:29067470 | Sfxn3 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Sfxn3 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of SFXN3 mRNA | CTD | PMID:37995155 | Sfxn3 | Rat | perfluorononanoic acid | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of SFXN3 mRNA | CTD | PMID:32588087 | Sfxn3 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Sfxn3 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of SFXN3 mRNA | CTD | PMID:36331819 | Sfxn3 | Rat | phenylmercury acetate | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of SFXN3 mRNA | CTD | PMID:26272509 | Sfxn3 | Rat | phenylmercury acetate | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Sfxn3 | Rat | potassium chromate | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SFXN3 mRNA | CTD | PMID:22714537 | Sfxn3 | Rat | progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of SFXN3 mRNA | CTD | PMID:20726854 | Sfxn3 | Rat | resveratrol | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of SFXN3 mRNA | CTD | PMID:23557933 | Sfxn3 | Rat | rotenone | increases expression | EXP | | 6480464 | Rotenone results in increased expression of SFXN3 protein | CTD | PMID:35544339 | Sfxn3 | Rat | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SFXN3 mRNA; [S-(1,2-dichlorovinyl)cysteine more ... | CTD | PMID:35811015 | Sfxn3 | Rat | SB 431542 | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Sfxn3 | Rat | sodium arsenite | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of SFXN3 mRNA | CTD | PMID:38568856 | Sfxn3 | Rat | sodium arsenite | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Sfxn3 | Rat | sotorasib | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SFXN3 mRNA | CTD | PMID:36139627 | Sfxn3 | Rat | sunitinib | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of SFXN3 mRNA | CTD | PMID:31533062 | Sfxn3 | Rat | temozolomide | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of SFXN3 mRNA | CTD | PMID:31758290 | Sfxn3 | Rat | Tesaglitazar | decreases expression | EXP | | 6480464 | tesaglitazar results in decreased expression of SFXN3 mRNA | CTD | PMID:21515302 | Sfxn3 | Rat | testosterone enanthate | affects expression | ISO | SFXN3 (Homo sapiens) | 6480464 | testosterone enanthate affects the expression of SFXN3 mRNA | CTD | PMID:17440010 | Sfxn3 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of SFXN3 mRNA | CTD | PMID:34492290 | Sfxn3 | Rat | thiram | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Thiram results in decreased expression of SFXN3 mRNA | CTD | PMID:38568856 | Sfxn3 | Rat | titanium dioxide | decreases methylation | ISO | Sfxn3 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SFXN3 enhancer | CTD | PMID:35295148 | Sfxn3 | Rat | titanium dioxide | decreases methylation | ISO | SFXN3 (Homo sapiens) | 6480464 | titanium dioxide results in decreased methylation of SFXN3 3' UTR; titanium dioxide results in decreased more ... | CTD | PMID:34973136 | Sfxn3 | Rat | trametinib | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of SFXN3 mRNA | CTD | PMID:36139627 | Sfxn3 | Rat | triclosan | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Triclosan results in increased expression of SFXN3 mRNA | CTD | PMID:30510588 | Sfxn3 | Rat | tunicamycin | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of SFXN3 mRNA | CTD | PMID:22378314 | Sfxn3 | Rat | uranium atom | affects expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Uranium affects the expression of SFXN3 mRNA | CTD | PMID:15672453 | Sfxn3 | Rat | valproic acid | affects expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of SFXN3 mRNA | CTD | PMID:25979313 | Sfxn3 | Rat | valproic acid | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SFXN3 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:24935251|PMID:26272509|PMID:27188386|PMID:28001369 | Sfxn3 | Rat | valproic acid | multiple interactions | ISO | SFXN3 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Sfxn3 | Rat | vincristine | increases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | Vincristine results in increased expression of SFXN3 mRNA | CTD | PMID:23649840 | Sfxn3 | Rat | zoledronic acid | decreases expression | ISO | SFXN3 (Homo sapiens) | 6480464 | zoledronic acid results in decreased expression of SFXN3 mRNA | CTD | PMID:20977926 | |






















